Genesis Plastics Welding Growing Fortville, Indiana, Facility
03/02/2011
"Genesis Plastics Welding has been headquartered in Indiana for nearly 25 years," said Tom Ryder, company president and CEO. "We have continually invested in our employees, technology, equipment, and facilities to maintain our competitive edge in the global marketplace. Indiana has always been a significant contributor to our success. Through the years, we have benefited from the state's affordable and talented work force, pro-business policies, and central geographic location."
The Indiana Economic Development Corporation has offered Genesis Plastics Welding up to $340,000 in performance-based tax credits. The town of Fortville will consider additional property tax abatement at the request of the Hancock Economic Development Council.
Genesis will add 50,000 square feet of production space, including a new ISO Class 7 Standard certified medical clean room, to its existing facility.
Project Announcements
Republic Airways Holdings Plans Tuskegee, Alabama, Training Operations
04/18/2024
South Africa-Based Radel Plans Winston-Salem, North Carolina, Operations
04/18/2024
Firestone Industrial Products Expands Dyersburg, Tennessee, Operations
04/18/2024
Samsung Electronics Expands Taylor, Texas, Chip-Manufacturing Operations
04/18/2024
OMCO Solar Plans Huntsville, Alabama, Production Operations
04/18/2024
Martco-RoyOMartin Upgrades Allen Parish, Louisiana, Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024